TREATMENT OF DEPRESSION ASSOCIATED WITH CEREBROVASCULAR DISEASE (ACCORDING TO THE DATA OF THE RESONANCE RUSSIAN MULTICENTER NATURALISTIC STUDY)
- Authors: Vorobyeva O.1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University
- Issue: Vol 23, No 12 (2012)
- Pages: 26-29
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115549
- ID: 115549
Cite item
Open Access
Access granted
Abstract
Eighty-eight patients with depression and comorbid cerebrovascular disease were treated with Valdoxan (25-50 mg/day) in the Resonance Russian multicenter naturalistic study. Following 6-week therapy, depressive symptomatology was relieved in the vast majority (82.35%) of patients. 17-item Hamilton Depression Rating Scale (HAMD-17) scores decreased from 15.8±3.6 to 5.0±2.7 (p<0.00001). There was also a reduction in the intractable symptoms of depression (fatigability, low work efficiency, dyssomnia) and their negative impact on patient functioning.
Full Text
About the authors
O. Vorobyeva
I.M. Sechenov First Moscow State Medical University
Email: oworobeva@mail.ru
Professor MD
References
- Alexopoulos G., Meyers B., Young R. et al. Vasculardepression’ hypothesis // Arch. Gen. Psychiatry. - 1997; 54: 915-22.
- Krishnan K., Hays J., Blazer D. MRI-defined vascular depression // Am. J. Psychiatry. 1997; 154: 497-501.
- Navarro V., Gasto C., Lomena F. et al. Normalization of frontal cerebral perfusion in remitted elderly major depression: a 12-month follow-up SPECT study // Neuroimage. - 2002; 16: 781-7.
- Kusumi I., Koyama T., Yamashita I. Serotonin-stimulated Ca2+ response in increased in the blood platelets of depressed patients // Biol. Psychiatry. - 1991; 30: 310-2.
- Sapolsky R. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders // Arch. Gen. Psychiatry. - 2000; 57: 925-35.
- Jonathan W. Strong Tie Links Depression, Stroke, but What's Binding Them? // Psychiatric. News. - 2011; 46: 2-23.
- Everson S., Roberts R., Goldberg D. et al. Depressive symptoms and increased risk of stroke mortality over a 29-year period // Arch. Intern. Med. - 1998; 158: 1133-8.
Supplementary files
